August 13th 2025, 1:00pm
Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera.
August 12th 2025, 8:00pm
A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.
August 12th 2025, 1:00pm
A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance of hisloved ones.
August 12th 2025, 12:10pm
Panelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple myeloma, while expressing optimism about emerging therapies like CAR T cells that offer deeper remissions and improved quality of life.
August 12th 2025, 12:05pm
Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T cell engagers, along with potent new CELMoD drugs, all offering more targeted and effective options for patients.
August 12th 2025, 12:00pm
Panelists discuss City of Hope’s collaborative partnership with community physicians, emphasizing expert evaluation at specialized centers while enabling ongoing treatment closer to home for convenience, coordinating common therapies like Daratumumab locally, reserving complex procedures such as stem cell transplants and clinical trials for specialized centers, and aiming to balance high-quality care with patient accessibility through integrated, personalized, and coordinated management across care settings.
August 11th 2025, 8:00pm
In an interview with CURE, medical oncologist Dr. Ioana Bonta explains why lung cancer is not just a ‘smoker’s disease.’
August 11th 2025, 1:00pm
Advancements in transplant medicine for blood cancers have prompted updates in how doctors choose donors for allogeneic hematopoietic cell transplants.
August 8th 2025, 8:00pm
Clara Cirks is a stage 4 lung cancer patient who uses platforms like TikTok and Instagram to amplify her voice and raise awareness about patient advocacy
August 8th 2025, 1:00pm
Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.
Understanding Your Diagnosis: Stage 2 Oral Cavity Cancer
Understanding Your Diagnosis of Bile Duct Cancer
Understanding Your Stage 2 Uterine (Endometrial) Cancer
Top Blood Cancer Stories from October: Key Updates for Patients